Tag: HRT safety

The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?

A review published in Postgraduate Medicine examined the safety and efficacy of bioidentical hormones (progesterone, estradiol, and estriol) compared to synthetic and animal-derived hormones used in hormone replacement therapy (HRT). The study found that patients reported greater satisfaction with HRT containing bioidentical progesterone over synthetic progestins. Clinical and physiological data

Read More »

The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use

A review by the National Academies of Sciences, Engineering, and Medicine examined the safety, effectiveness, and clinical utility of compounded bioidentical hormone therapy (cBHT) as an alternative to FDA-approved hormone therapies. The report highlights concerns about the widespread use of cBHT despite insufficient evidence supporting its safety and efficacy. It

Read More »

Progestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue

This study examines the impact of different progestagens in hormone replacement therapy (HRT) on breast cancer risk among postmenopausal women. Published in Gynecological Endocrinology (2009), it discusses how various progestins may influence breast cancer cell behavior differently, with some evidence suggesting that certain progestins could enhance the proliferation and invasiveness

Read More »